Cancer vaccines: From therapy to primary prevention

Medical research is advancing towards the development of cancer vaccines, shifting the focus from therapeutic applications to primary prevention. Scientists aim to leverage immunological responses to either treat existing tumors or prevent the onset of the disease entirely. This evolution in oncology represents a significant breakthrough, as clinical studies continue to evaluate the efficacy and safety of these vaccines in different populations to improve survival rates and reduce cancer incidence.